Société eFFECTOR Therapeutics, Inc.
Actions
EFTR
US28202V2079
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,07 USD | +9,52% | +16,29% | -82,28% |
Métier
Nombre d'employés: 14
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01/12/20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/08/22 |
Mark Densel
PRN | Corporate Officer/Principal | - | 01/11/18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 26/09/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Director/Board Member | 54 | 25/08/21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11/09/23 |
Brian Gallagher
CHM | Chairman | 54 | 01/01/20 |
Barbara Klencke
BRD | Director/Board Member | 66 | 01/11/21 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 25/08/21 |
Director/Board Member | 51 | 15/02/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 716 409 | 3 553 586 ( 75,35 %) | 0 | 75,35 % |
Coordonnées société
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-82,28% | 9,74 M | |
-2,63% | 102 Md | |
+1,62% | 96,29 Md | |
+1,78% | 22,18 Md | |
-16,67% | 21,2 Md | |
-8,79% | 18,31 Md | |
-38,74% | 17,38 Md | |
-13,21% | 16,36 Md | |
+5,41% | 13,97 Md | |
+33,57% | 12,17 Md |
- Bourse
- Actions
- Action EFTR
- Société eFFECTOR Therapeutics, Inc.